Filter
63
Text search:
research
and
ethics
clearance
Featured
Recommendations
7
New Publications
19
Language
Document type
No document type
34
Studies & Reports
11
Manuals
7
Guidelines
7
Training Material
2
Strategic & Response Plan
2
Countries / Regions
Tanzania
4
India
3
Ukraine
3
Global
3
Nigeria
2
Cameroon
2
Ghana
2
Zambia
2
South Africa
2
Bangladesh
2
Lesotho
2
Myanmar / Burma
2
Western and Central Europe
2
Congo, Democratic Republic of
1
Ethiopia
1
Haiti
1
Syria
1
Kenya
1
Rwanda
1
Indonesia
1
Malawi
1
Brazil
1
Sri Lanka
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe
1
Southern Africa
1
Tajikistan
1
Moldova
1
Kyrgyzstan
1
Kazakhstan
1
Authors & Publishers
Publication Years
Category
Countries
37
Women & Child Health
5
Clinical Guidelines
4
Public Health
3
Key Resources
2
Capacity Building
1
Toolboxes
NTDs
6
COVID-19
4
Conflict
3
Disability
2
HIV
2
Mental Health
2
TB
2
Planetary Health
2
Ebola & Marburg
1
Natural Hazards
1
Rapid Response
1
Refugee
1
Zika
1
Global Health Education
1
AMR
1
Social Ethics
1
Caregiver
1
Pharmacy
1
NCDs
1
Malaria
1
Introduction, preparations to submit, submission procedure, requirements, main narrative of the protocol, definition of terms. | For Research and ethics
...
Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis: learners’ guide. World Health Organization.
A report submitted to the International Labour Organization, Geneva
This report outlines the Ministry of Health’s National Health Research Agenda in which it identifies research priorities in health. It will be implemented in the same time frame as the Health Sect
...
Report on Main Findings
The review encompasses three complementary components: 1) a review of published literature 2000-2015 on NCDs and their risk factors; 2) qualitative interviews with key actors engaged in NCD ...
The review encompasses three complementary components: 1) a review of published literature 2000-2015 on NCDs and their risk factors; 2) qualitative interviews with key actors engaged in NCD ...
The Quadripartite organizations have developed the One Health Priority Research Agenda for AMR report, this is a joint initiative to assist in directing and catalysing scientific interest
...
Mpox continues to affect people around the world. A new framework released today by WHO will guide health authorities, communities and other stakeholders in preventing and controlling mpox outbreaks
...
Hindawi Publishing Corporation
Tuberculosis Research and Treatment
Volume 2015, Article ID 752709, 7 pages
Leptospirosis is a bacterial zoonotic disease of worldwide importance, though relatively neglected in many African countries including sub Saharan Africa that is among areas with high burden of this disease. The disease is often mistaken for other febrile illnesses such as dengue, malaria, rickettsi
...
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership
...
Naicker et al. BMC Palliative Care (2016) 15:41 DOI 10.1186/s12904-016-0114-7
This recommendation is an update of one of the 49 recommendations that were published in the WHO recommendations on antenatal care for a positive pregnancy experience. The recommendation was developed initially using the standardized operating procedures described in the WHO handbook for guideline d
...
DHS Working Papers No. 85
This document provides guidance to Member States in the WHO European Region that wish to conduct behavioural insights studies related to COVID-19. Studies can be used to monitor public knowledge, risk perceptions, behaviours and trust with the overa
...
PLoS ONE 13(8): e0202499. https://doi.org/10.1371/journal.pone.0202499
This was a school-based cross-sectional study conducted in 2015 among 305 school children aged 7–16 years from two primary schools located in Ilemela and Magu Districts, north
...
Int J Ment Health Syst. 2013 Jan 9;7(1):2. doi: 10.1186/1752-4458-7-2.
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
